UK markets closed

Amphastar Pharmaceuticals, Inc. (AMPH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.68+0.22 (+0.52%)
At close: 04:00PM EDT
42.68 0.00 (0.00%)
After hours: 04:16PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
644,395
644,395
498,987
437,768
349,846
Cost of revenue
293,274
293,274
250,127
238,029
206,506
Gross profit
351,121
351,121
248,860
199,739
143,340
Operating expenses
Research development
73,741
73,741
74,771
60,932
67,229
Selling general and administrative
80,393
80,393
66,592
68,920
65,157
Total operating expenses
154,134
154,134
141,363
129,852
132,386
Operating income or loss
196,987
196,987
107,497
69,887
10,954
Interest expense
27,158
27,158
1,846
885
374
Total other income/expenses net
-3,929
-3,929
9,068
14,536
-6,585
Income before tax
171,359
171,359
116,040
84,139
4,637
Income tax expense
31,833
31,833
23,477
20,630
3,540
Income from continuing operations
137,545
137,545
91,386
63,301
1,097
Net income
137,545
137,545
91,386
62,116
1,403
Net income available to common shareholders
137,545
137,545
91,386
62,116
1,403
Basic EPS
2.80
2.85
1.88
1.30
0.03
Diluted EPS
2.56
2.60
1.74
1.25
0.03
Basic average shares
48,351
48,265
48,551
47,777
47,038
Diluted average shares
52,676
53,001
52,427
49,784
49,124